Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tripodi

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 7, 2017
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: commentA Tripodi
Thrombosis and Haemostasis|October 6, 2000
Control of oral anticoagulant therapy with whole blood prothrombin time devices: the future has begunA Tripodi
Journal of Thrombosis and Haemostasis : JTH|October 10, 2006
Performance of quantitative D-dimer methods: results of the Italian external quality assessment schemeA Tripodi, V Chantarangkul
Journal of Thrombosis and Haemostasis : JTH|July 19, 2011
More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes requiredA Tripodi, V Pengo
Journal of Thrombosis and Haemostasis : JTH|August 14, 2012
The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulationA Tripodi, M Moia
Journal of Internal Medicine|March 27, 2012
New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillationA Tripodi, G Palareti
American Journal of Clinical Pathology|September 1, 1986
Factor VIII activity as measured by an amidolytic assay compared with a one-stage clotting assayA Tripodi, P M Mannucci
Clinical Chemistry|May 1, 1996
Markers of activated coagulation and their usefulness in the clinical laboratoryA Tripodi, P M Mannucci
Thrombosis and Haemostasis|August 26, 1998
Monitoring warfarin therapy in patients with lupus anticoagulants (LA)A Tripodi, P M Mannucci
Blood Reviews|March 1, 1988
Inherited factors in thrombosisP M Mannucci, A Tripodi
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Journal of Thrombosis and Haemostasis : JTH|June 7, 2017
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: commentA Tripodi
Thrombosis and Haemostasis|October 6, 2000
Control of oral anticoagulant therapy with whole blood prothrombin time devices: the future has begunA Tripodi
Journal of Thrombosis and Haemostasis : JTH|October 10, 2006
Performance of quantitative D-dimer methods: results of the Italian external quality assessment schemeA Tripodi, V Chantarangkul
Journal of Thrombosis and Haemostasis : JTH|July 19, 2011
More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes requiredA Tripodi, V Pengo
Journal of Thrombosis and Haemostasis : JTH|August 14, 2012
The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulationA Tripodi, M Moia
Journal of Internal Medicine|March 27, 2012
New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillationA Tripodi, G Palareti
American Journal of Clinical Pathology|September 1, 1986
Factor VIII activity as measured by an amidolytic assay compared with a one-stage clotting assayA Tripodi, P M Mannucci
Clinical Chemistry|May 1, 1996
Markers of activated coagulation and their usefulness in the clinical laboratoryA Tripodi, P M Mannucci
Thrombosis and Haemostasis|August 26, 1998
Monitoring warfarin therapy in patients with lupus anticoagulants (LA)A Tripodi, P M Mannucci
Blood Reviews|March 1, 1988
Inherited factors in thrombosisP M Mannucci, A Tripodi
Pageof 28